Pathologies affecting the posterior segment of the eye are one of the major causes of
blindness in developed countries and are becoming more prevalent due to the increase in …

A variety of ocular drug delivery systems, including a controlled release of the drug, drug
targeting, and penetration enhancement of the drug, have been investigated. Biodegradable …

5,589,376 A 12/1996 Anderson et a1......... 435/240.2 5,670,483 A* 9/1997 zhang et
31'""""""""" 514/14 Cells derivedfromhumanumbilical cords are disclosedalong 5,677,181 A …

(57) ABSTRACT A process and apparatus for rapidly producing an emulsion and
microcapsules in a simple manner is provided wherein a dispersion phase is ejected from a …

2004-12-16 Assigned to ETHICON, INCORPORATED reassignment ETHICON,
INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

The present invention provides a flowable composition suitable for use as a controlled
release implant. The flowable composition can be administered into the ocular region of a …

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C (= O) C (NC (= O)
C (CCC (N)= O) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (NC (= O) CN) C …

4,882,162 A 11, 1989 Ikada et al......... 424/444 placebo-controlled, clinical trial of high-dose
Supplementation with 4,963,489 A 10/1990 Naughton et al. 435.240. 1 vitamins C and E …

US20060153815A1 - Tissue engineering devices for the repair and regeneration of tissue -
Google Patents US20060153815A1 - Tissue engineering devices for the repair and regeneration …

The present invention relates to a rapamycin Sustained release delivery system for
treatment of diseases responsive to rapa mycin. The sustained release delivery system of …